Global Medical REIT Inc. (NYSE:XRN) Given Consensus Rating of “Hold” by Analysts

Posted by Geri Gentry on Jun 10th, 2026

Shares of Global Medical REIT Inc. (NYSE:XRN – Get Free Report) have been assigned an average rating of “Hold” from the seven analysts that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, two have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $40.00.

Several research analysts have issued reports on the company. Citizens Jmp boosted their target price on Global Medical REIT from $40.00 to $42.00 and gave the company a “market outperform” rating in a research report on Tuesday, May 26th. Wall Street Zen downgraded Global Medical REIT from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. BMO Capital Markets boosted their price objective on Global Medical REIT from $33.00 to $39.00 and gave the company a “market perform” rating in a report on Monday, May 18th. Weiss Ratings downgraded Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, May 11th. Finally, Compass Point reiterated a “neutral” rating and issued a $38.00 target price (down from $50.00) on shares of Global Medical REIT in a research note on Thursday, May 7th.

Read Our Latest Analysis on XRN

Global Medical REIT Trading Up 2.7%

Shares of XRN opened at $36.99 on Wednesday. The company’s fifty day simple moving average is $35.11 and its 200-day simple moving average is $35.01. The company has a market cap of $489.38 million, a P/E ratio of -33.32 and a beta of 1.11. The company has a current ratio of 0.68, a quick ratio of 0.68 and a debt-to-equity ratio of 1.68. Global Medical REIT has a twelve month low of $29.05 and a twelve month high of $39.93.

Global Medical REIT Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Friday, September 18th. Investors of record on Thursday, August 20th will be paid a $0.16 dividend. This represents a c) annualized dividend and a yield of 5.2%. The ex-dividend date of this dividend is Thursday, August 20th. Global Medical REIT’s dividend payout ratio (DPR) is currently -270.27%.

Insider Activity at Global Medical REIT

In related news, Director Matthew Cypher acquired 1,420 shares of the stock in a transaction on Thursday, May 14th. The stock was bought at an average cost of $35.12 per share, with a total value of $49,870.40. Following the transaction, the director directly owned 1,690 shares in the company, valued at approximately $59,352.80. This represents a 525.93% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Paula Crowley bought 1,000 shares of Global Medical REIT stock in a transaction dated Monday, May 11th. The shares were bought at an average cost of $34.00 per share, for a total transaction of $34,000.00. Following the completion of the transaction, the director owned 1,000 shares of the company’s stock, valued at approximately $34,000. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 10,974 shares of company stock worth $373,826 over the last ninety days. 8.90% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Global Medical REIT

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd boosted its stake in shares of Global Medical REIT by 1,001.4% during the third quarter. Caitong International Asset Management Co. Ltd now owns 793 shares of the company’s stock valued at $27,000 after purchasing an additional 721 shares in the last quarter. Fifth Third Bancorp bought a new position in Global Medical REIT in the third quarter worth approximately $35,000. Virtus Advisers LLC lifted its holdings in Global Medical REIT by 46.5% during the fourth quarter. Virtus Advisers LLC now owns 2,418 shares of the company’s stock worth $82,000 after buying an additional 768 shares during the period. Eurizon Capital SGR S.p.A. purchased a new stake in Global Medical REIT during the fourth quarter worth $92,000. Finally, SG Americas Securities LLC bought a new stake in Global Medical REIT during the 4th quarter valued at $121,000. Institutional investors own 57.52% of the company’s stock.

Global Medical REIT Company Profile

(Get Free Report)

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.